Evidence map›Paper›PMID 22972495›Full record

ReviewCurrent HIV/AIDS reports2012

Interventions to address chronic disease and HIV: strategies to promote smoking cessation among HIV-infected individuals.

Raymond Niaura, Geetanjali Chander, Heidi Hutton, Cassandra Stanton

Abstract readReview
In one paragraph

Review in Current HIV/AIDS reports, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Prize-Based Incentives for Smoking Cessation Among People With HIV: A Sequential Multiple Assignment Randomized Trial.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2025
    Trial
  3. Impact of Smoking Cessation Interventions Initiated During Hospitalization Among HIV-Infected Smokers.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2020
    Trial
  4. Trial
  5. Correlates of Adherence to Varenicline Among HIV+ Smokers.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2015
    Trial
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Time-varying copula models for longitudinal data.Statistics and its interface · 2018
    Article
  13. Article
  14. Article
  15. A semivarying joint model for longitudinal binary and continuous outcomes.The Canadian journal of statistics = Revue canadienne de statistique · 2016
    Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Raymond NiauraSchroeder Institute for Tobacco Research and Policy Studies, Legacy, 1724 Massachusetts Avenue NW, Washington, DC 20036, USA. rniaura@legacyforhealth.org
Geetanjali Chander
Heidi Hutton
Cassandra Stanton
Johns Hopkins University · USAmerican Legacy Foundation · USGeorgetown University · US

Funding

Ethnic Health/Motivating HIV+ Latinos to Quit SmokingR01DA018079 · NIDA · BUTLER HOSPITAL (PROVIDENCE, RI) · PI STANTON, CASSANDRA A · 2005 to 2009
$2.8M
MOTIVATION AND PATCH TREATMENT FOR HIV POSITIVE SMOKERSR01DA012344 · NIDA · MIRIAM HOSPITAL · PI LLOYD-RICHARDSON, ELIZABETH E · 1999 to 2003
$2.0M
NIDA NIH HHS R01 DA012344NIDA NIH HHS R01 DA018079
6 · The paper itself

Abstract

Tobacco use, especially cigarette smoking, is higher than average in persons living with HIV/AIDS (PLWHA). The Public Health Service Clinical Practice Guideline for Treating Tobacco Use and Dependence states that, during every medical encounter, all smokers should be offered smoking cessation counseling, along with approved medications. The Guideline also recognizes PLWHA as a priority population, given the scarcity of research on effective cessation treatments in this group. The scant evidence suggests that conventional treatments, though worthwhile, are not as successful as might be hoped for. The reasons for this are not entirely clear, but may have to do with the complex array of medical and psychosocial factors that complicate their lives. Clinicians should consider re-treatment strategies for those patients who encounter difficulty when quitting smoking with conventional approaches, switching or augmenting treatments as needed to minimize adverse experiences, and to maximize tolerability, adherence, and cessation outcomes.

Indexed as

Drug MonitoringAcquired Immunodeficiency SyndromeCardiovascular DiseasesFemaleHealth Knowledge, Attitudes, PracticeHealth PromotionHIV SeropositivityHumansMaleSmokingSmoking CessationSocioeconomic FactorsUnited States

Identifiers

PMID22972495
PMCPMC3566982
OpenAlexW2059429068

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.